Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000093751-26-000634·Compass Therapeutics, Inc.
Schedule 13G ownership disclosure
Compass Therapeutics Inc
COMMON STOCK · CUSIP: 20454B104
Event date: 2026-09-30
- Filing-level shares
- 7,737,938.00
- Percent of class
- 4.3%
- STATE STREET CORPORATION
Shares: 7,737,938.00 · Class: 4.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000093751-26-000634
- Form type
- SCHEDULE 13G
- Filer
- Compass Therapeutics, Inc.
- CIK
- CIK 1738021
- Filed
- Nov 10, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership